Machine Learning and Drug Discovery
Yesterday, Recursion Pharmaceuticals announced that the Food and Drug Administration had cleared their investigational new drug application for a Phase 1 clinical trial in the treatment of cerebral cavernous malformation (CCM). While this is certainly good news for treating this rare genetic disease, it is also an important milestone in the use of machine learning […]